Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021

Publisher Name :
Date: 31-Aug-2016
No. of pages: 161

The global preclinical imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is expected to be valued at USD 910.4 million by 2021. Although the mature markets (North America and Europe) held large share of preclinical imaging market in 2015; Asia-Pacific region is poised to be the fastest growing region during next five years. Factors such as continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries are propelling the growth of the preclinical imaging market in Asia-Pacific region.

Market growth in the global preclinical imaging market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.

Geographically, North America is estimated to command the largest share of the global preclinical imaging market in 2016, followed by Europe. The large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems. However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by the Canadian government to support research studies are negatively affecting the growth of the preclinical imaging market in this region.

The preclinical imaging market isfairly competitive, with a large number of global and local manufacturers of preclinical imaging solutions. PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the preclinical imaging market in 2015. These companies together accounted for a share of 63.2% of the global preclinical imaging market in 2015. New product launches and product enhancements; geographic expansions; and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market.

Report Objective:

This report studies preclinical imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.

The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the preclinical imaging market report analyzes the micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market.

Detailed Segmentation:

Preclinical Imaging Market, by Modality


  • Optical Imaging Systems

    • Bioluminescence/Fluorescence Imaging Systems

    • Standalone Fluorescence Imaging Systems

    • Optical + X-Ray/Optical + CT



  • Preclinical Nuclear Imaging Systems

    • Micro-PET Systems

    • Micro-SPECT Systems

    • Trimodality (SPECT/PET/CT) Systems



  • Micro-MRI Systems

  • Micro-Ultrasound Systems

  • Micro-CT Systems

  • Preclinical Photoacoustic Imaging Systems

  • Preclinical Magnetic Particle Imaging (MPI) Systems


Preclinical Imaging Market, by Reagents


  • Preclinical Optical Imaging Reagents

    • Bioluminescent Imaging Reagents

    • Fluorescent Imaging Reagents



  • Preclinical Nuclear Imaging Reagents

    • Preclinical PET Tracers

    • Preclinical SPECT Probes



  • Preclinical MRI Contrast Agents

    • Gadolinium-based Preclinical MRI Contrast Agents

    • Iron-based Preclinical MRI Contrast Agents

    • Manganese-based Preclinical MRI Contrast Agents



  • Preclinical Ultrasound Contrast Agents

  • Preclinical CT Contrast Agents

    • Iodine-based Preclinical CT Contrast Agents

    • Barium-based Preclinical CT Contrast Agents

    • Gold Nanoparticles

    • Gastrografin-based Preclinical CT Contrast Agents




Preclinical Imaging Market, by Region


  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World


Key Target Audience:


  • Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers

  • Pharmaceutical and Biotechnology Companies

  • Preclinical Imaging Reagent Manufacturers and Suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities

Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Preclinical Imaging Market Definition
1.3 Preclinical Imaging Market Scope
1.3.1 Markets Covered
1.3.1.1 Preclinical Imaging Market Segmentation
1.3.1.2 Preclinical Imaging Systems Market Segmentation
1.3.1.3 Preclinical Imaging Reagents Market Segmentation
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Preclinical Imaging Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Preclinical Imaging Market Breakdown and Data Triangulation
2.4 Research Assumptions & Limitations
2.4.1 Assumptions

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Global Preclinical Imaging Market Overview
4.2 Preclinical Imaging Products Market Share, By Region (2016)
4.3 Global Preclinical Imaging Systems Market, By Modality (2016–2021)
4.4 Global Preclinical Imaging Reagents Market, By Type (2016–2021)
4.5 Preclinical Imaging Market, By Region (2016 vs 2021)

5 Preclinical Imaging Market Overview
5.1 Introduction
5.2 Preclinical Imaging Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Technological Advancements in the Field of Molecular Imaging
5.2.1.2 Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
5.2.1.3 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches
5.2.2 Key Market Restraints
5.2.2.1 Strict Regulations Governing Preclinical Research
5.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities
5.2.3 Key Market Opportunity
5.2.3.1 Emerging Markets to Offer New Growth Opportunities
5.2.4 Key Market Challenge
5.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems

6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Stakeholders
6.3.2 Key Influencers
6.4 Industry Trends
6.4.1 Ongoing Development of Hybrid and Multi-Modality Preclinical Imaging Systems
6.5 Porter’s Five Forces Analysis
6.5.1 Threat of New Entrants
6.5.2 Threat of Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry

7 Global Preclinical Imaging Market, By Modality
7.1 Introduction
7.2 Optical Imaging Systems
7.2.1 Bioluminescence/Fluorescence Imaging Systems
7.2.2 Standalone Fluorescence Imaging Systems
7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
7.3 Nuclear Imaging Systems
7.3.1 Micro-PET Systems
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 Micro-Spect Systems
7.3.2.1 Standalone Spect Systems
7.3.2.2 Spect/CT Systems
7.3.2.3 Spect/MRI Systems
7.3.3 Trimodality (Spect/PET/CT) Systems
7.4 Micro-MRI
7.5 Micro-Ultrasound
7.6 Micro-CT
7.7 Photoacoustic Imaging Systems
7.8 Magnetic Particle Imaging (MPI) Systems

8 Global Preclinical Imaging Market, By Reagent
8.1 Introduction
8.2 Preclinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 Fluorescent Imaging Reagents
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other Fluorescent Imaging Reagents
8.3 Preclinical Nuclear Imaging Reagents
8.3.1 Preclinical PET Tracers
8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
8.3.1.2 Carbon-11-Based Preclinical PET Tracers
8.3.1.3 Copper-64-Based Preclinical PET Tracers
8.3.1.4 Other PET Tracers
8.3.2 Preclinical Spect Probes
8.3.2.1 Technetium-99m-Based Preclinical Spect Probes
8.3.2.2 Iodine-131-Based Preclinical Spect Probes
8.3.2.3 Gallium-67-Based Preclinical Spect Probes
8.3.2.4 Thallium-201-Based Preclinical Spect Probes
8.3.2.5 Other Spect Probes
8.4 Preclinical MRI Contrast Agents
8.4.1 Gadolinium-Based Preclinical Contrast Agents
8.4.2 Iron-Based Preclinical Contrast Agents
8.4.3 Manganese-Based Preclinical Contrast Agents
8.5 Preclinical Ultrasound Contrast Agents
8.6 Preclinical CT Contrast Agents
8.6.1 Iodine-Based Preclinical CT Contrast Agents
8.6.2 Barium-Based Preclinical CT Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-Based Preclinical CT Contrast Agents

9 Preclinical Imaging Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
10.3 Competitive Scenario
10.3.1 New Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Geographical Expansions
10.3.4 Acquisitions

11 Company Profiles
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Perkinelmer, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments (2013-2016)
11.2.4 MnM View
11.3 Bruker Corporation
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments (2013-2016)
11.3.4 MnM View
11.4 Fujifilm Holdings Corporation
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments (2013-2016)
11.4.4 MnM View
11.5 Mediso Ltd.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments (2013-2016)
11.6 Milabs B.V.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments (2013-2016)
11.7 MR Solutions Ltd.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments (2013-2016)
11.8 Aspect Imaging Ltd.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments (2013-2016)
11.9 Li-Cor Biosciences
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments (2013-2016)
11.10 Trifoil Imaging
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments (2013-2016)
11.11 Miltenyi Biotec GmbH
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments (2013-2016)

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables

Table 1 Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 2 Global Optical Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 3 Optical Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 4 Bioluminescence/Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 5 Standalone Fluorescence Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 6 Optical + X-Ray/Optical + CT Imaging Systems Market Size, By Region, 2012–2014 (USD Million)
Table 7 Global Nuclear Imaging Systems Market Size, By Type, 2014–2021 (USD Million)
Table 8 Nuclear Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Micro-PET Systems Market Size, By Type, 2014–2021 (USD Million)
Table 10 Micro-PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 11 Standalone PET Systems Market Size, By Region, 2014–2021 (USD Million)
Table 12 PET/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 13 PET/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 14 Global Micro-Spect Systems Market Size, By Type, 2014–2021 (USD Million)
Table 15 Micro-Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 16 Standalone Spect Systems Market Size, By Region, 2014–2021 (USD Million)
Table 17 Spect/CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Spect/MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 19 Trimodality Systems Market Size, By Region, 2014–2021 (USD Million)
Table 20 Micro-MRI Systems Market Size, By Region, 2014–2021 (USD Million)
Table 21 Micro-Ultrasound Systems Market Size, By Region, 2014–2021 (USD Million)
Table 22 Micro-CT Systems Market Size, By Region, 2014–2021 (USD Million)
Table 23 Photoacoustic Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 24 Magnetic Particle Imaging Systems Market Size, By Region, 2014–2021 (USD Million)
Table 25 Global Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 26 Global Preclinical Optical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 27 Preclinical Optical Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 28 Global Preclinical Bioluminescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 29 Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Preclinical Luciferins Market Size, By Region, 2014–2021 (USD Million)
Table 31 Preclinical Proluciferins Market Size, By Region, 2014–2021 (USD Million)
Table 32 Preclinical Coelenterazine Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other Preclinical Bioluminescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 34 Global Preclinical Fluorescent Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 35 Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 36 Preclinical Green Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 37 Preclinical Red Fluorescent Proteins Market Size, By Region, 2014–2021 (USD Million)
Table 38 Preclinical Infrared Dyes Market Size, By Region, 2014–2021 (USD Million)
Table 39 Other Preclinical Fluorescent Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 40 Global Preclinical Nuclear Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 41 Preclinical Nuclear Imaging Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 42 Global Preclinical PET Tracers Market Size, By Type, 2014–2021 (USD Million)
Table 43 Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 44 Fluorine-18-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 45 Carbon-11-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 46 Copper-64-Based Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 47 Other Preclinical PET Tracers Market Size, By Region, 2014–2021 (USD Million)
Table 48 Global Preclinical Spect Probes Market Size, By Type, 2014–2021 (USD Million)
Table 49 Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 50 Technetium-99m-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 51 Iodine-131-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 52 Gallium-67-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 53 Thallium-201-Based Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 54 Other Preclinical Spect Probes Market Size, By Region, 2014–2021 (USD Million)
Table 55 Global Preclinical MRI Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 56 Preclinical MRI Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 57 Gadolinium-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 58 Iron-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 59 Manganese-Based Preclinical Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 60 Preclinical Ultrasound Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 61 Global Preclinical CT Contrast Agents Market Size, By Type, 2014–2021 (USD Million)
Table 62 Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 63 Iodine-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 64 Barium-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 65 Gold Nanoparticles Market Size, By Region, 2014–2021 (USD Million)
Table 66 Gastrografin-Based Preclinical CT Contrast Agents Market Size, By Region, 2014–2021 (USD Million)
Table 67 Global Preclinical Imaging Systems and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 68 North America: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 69 North America: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 70 North America: Preclinical Imaging Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 71 Europe: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 72 Europe: Preclinical Imaging Systems Market Size, By Modality, 2014–2021 (USD Million)
Table 73 Europe: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 76 Asia-Pacific: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoW: Preclinical Imaging Market Size, By Product, 2014–2021 (USD Million)
Table 78 RoW: Preclinical Imaging Systems Market Size, By Modality, 2014-2021 (USD Million)
Table 79 RoW: Preclinical Imaging Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 80 Top New Product Launches, 2013–2016
Table 81 Top Agreements, Partnerships, and Collaborations, 2013–2016
Table 82 Top Geographical Expansions, 2013–2016
Table 83 Top Acquisitions, 2013–2016

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 Pre-clinical Imaging Systems Market: Bottom-Up Approach
Figure 4 Pre-clinical Imaging Systems Market: Top-Down Approach
Figure 5 Pre-clinical Imaging Reagents Market: Top-Down Approach
Figure 6 Preclinical Imaging Market: Data Triangulation
Figure 7 Global Preclinical Imaging Systems Market, By Modality, 2016 vs 2021 (USD Million)
Figure 8 Global Preclinical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Preclinical Imaging Market, By Region, 2016 (USD Million)
Figure 10 Technological Advancements in Molecular Imaging and Increasing Demand for Noninvasive Techniques—Key Market Drivers
Figure 11 North America is Expected to Dominate the Preclinical Imaging Market in 2016
Figure 12 Optical Imaging, Nuclear Imaging, and Micro-MRI Systems to Dominate the Preclinical Imaging Systems Market Till 2021
Figure 13 Optical Imaging and Nuclear Imaging Reagents to Dominate the Preclinical Imaging Reagents Market Till 2021
Figure 14 North America to Command the Largest Share of the Preclinical Imaging Market in 2016
Figure 15 Technological Advancements & Emerging Application Segments to Drive the Growth of the Preclinical Imaging Market Till 2021
Figure 16 Healthcare Expenditure Across Major Countries, 2000–2013
Figure 17 Majority of Product Value of Preclinical Imaging Systems is Added During the Manufacturing and Assembly Phase
Figure 18 Market Players Prefer Both Direct & Indirect Distribution Strategies
Figure 19 Porter’s Five Forces Analysis: Preclinical Imaging Market (2015)
Figure 20 Optical Imaging Systems to Dominate Preclinical Imaging Systems Market Till 2021
Figure 21 Optical Imaging Systems Market, By Type
Figure 22 Nuclear Imaging Systems Market, By Type
Figure 23 Preclinical Imaging Reagents Market, By Type
Figure 24 Preclinical Optical Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 25 Preclinical Nuclear Imaging Reagents Market, By Type, 2016 vs 2021 (USD Million)
Figure 26 Preclinical MRI Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 27 Preclinical CT Contrast Agents Market, By Type, 2016 vs 2021 (USD Million)
Figure 28 Asia-Pacific to Be the Fastest-Growing Region in Global Preclinical Imaging Market Till 2021
Figure 29 North America: Preclinical Imaging Market Snapshot
Figure 30 Europe: Preclinical Imaging Market Snapshot
Figure 31 Asia-Pacific: Preclinical Imaging Market Snapshot (2016-2021)
Figure 32 RoW: Preclinical Imaging Market Snapshot (2016-2021)
Figure 33 New Product Launches: Key Growth Strategy Adopted By Majority of Market Players (2013-2016)
Figure 34 Global Preclinical Imaging Market Share, By Key Player (2015)
Figure 35 Increasing Number of New Products Launched is Stimulating the Preclinical Imaging Market Growth
Figure 36 Geographic Revenue Mix of the Top 3 Market Players (2015)
Figure 37 Perkinelmer, Inc.: Company Snapshot
Figure 38 Bruker Corporation: Company Snapshot
Figure 39 Fujifilm Holdings Corporation: Company Snapshot

  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast
    Published: 21-Feb-2017        Price: US 1150 Onwards        Pages: 49
    United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast is a research study published Renub Research. UK Proton Therapy Market is expected to grow with a CAGR of 82% in future. United Kingdom Proton Therapy Market is expected to grow 10 times from its current market in 2016. Currently UK has only one Proton Therapy facility, at Clatterbridge cancer center and it's a ‘low-energy' machine, only suitable for treating people with rare eye cance......
  • Global Veterinary Ultrasound System Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 11-Feb-2017        Price: US 3480 Onwards        Pages: 118
    Ultrasound Systems is a special medical device used in ultrasonography for diagnostic purpose. Ultrasonography, commonly known as ultrasound, is a popular medical imaging technique used in diagnostics, and which uses high-frequency sound pulses and their echoes to specific body regions. Ultrasonic waves are specifically helpful in visualizing or imaging subcutaneous or internal body structures including muscles, tendons, vessels, joints or internal organs for any pathology or lesions.......
  • Europe Veterinary Ultrasound System Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 11-Feb-2017        Price: US 4480 Onwards        Pages: 118
    Ultrasound Systems is a special medical device used in ultrasonography for diagnostic purpose. Ultrasonography, commonly known as ultrasound, is a popular medical imaging technique used in diagnostics, and which uses high-frequency sound pulses and their echoes to specific body regions. Ultrasonic waves are specifically helpful in visualizing or imaging subcutaneous or internal body structures including muscles, tendons, vessels, joints or internal organs for any pathology or lesions.......
  • Diagnostic Equipment Market Global Briefing 2017 Including: X-ray Systems, Ultrasound, CT Scanners, MRI Systems, Cardiovascular Monitoring and Diagnostic Devices, and Nuclear Imaging Devices Covering: Siemens Healthcare, Hitachi Medical Systems, GE Healthcare, Philips Healthcare, Fujifilm Holdings
    Published: 06-Feb-2017        Price: US 1000 Onwards        Pages: 26
    Diagnostic equipment is used for identifying the presence and cause of disease, assessing the nature of disease, designating a course of treatment, monitoring the effects of interventions and determining the recurrence of existing disease. The diagnostic equipment market doesn't include in-vitro diagnostics products that are used to detect diseases, infections and conditions by examining specimens derived from human body such as tissues, blood, stool, urine and other body fluids. ......
  • High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022
    Published: 06-Feb-2017        Price: US 1250 Onwards        Pages: 220
    More than 570 commercial treatment sites treated over 115, 000 cases with HIFU system throughout the world with great success. High Intensity Focused Ultrasound(HIFU) is a modality of therapeutic ultrasound and is a non–invasive method to deposit acoustic energy into tissue. In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue rises to 65° to 100°C, destroying the diseas......
  • Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers
    Published: 03-Feb-2017        Price: US 1150 Onwards        Pages: 51
    According to this report Germany Proton Therapy Industry has a market potential of US$ 2 Billion by 2021. Currently Germany has 6 operational proton therapy centers. Rising cancer incidence in Germany is the major key driver to boost Germany proton therapy market. Adoption of technological up-gradation that has more utilization rate will shorten the length of time per patient. In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report al......
  • France Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers
    Published: 02-Feb-2017        Price: US 1150 Onwards        Pages: 51
    France Proton Therapy Market is expected to be more than USD 1.5 Billion by the year 2021. France Proton Therapy actual market is expected to almost double in future from its current market size in 2016. So considering the need from patient perspective France had modified all two Proton Therapy Centers with latest technological up-gradation to enhance the capacity to treat more patients. Diversified range of advanced radiation therapy techniques and technologies are available, such as Intensi......
  • North America Contrast Agents Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 5995 Onwards        Pages: 116
    North America Contrast Agents Market Outlook to 2022 Summary GlobalData's new report, "North America Contrast Agents Market Outlook to 2022", provides key market data on the North America Contrast Agents market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles......
  • North America Contrast Media Injectors Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 5995 Onwards        Pages: 69
    North America Contrast Media Injectors Market Outlook to 2022 Summary GlobalData's new report, "North America Contrast Media Injectors Market Outlook to 2022", provides key market data on the North America Contrast Media Injectors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs